COIOSDeep risk insights through multi-disciplinary research across the globe
a group of people walking down a street next to tall buildings
Item confirms Peer-reviewed Added

Two in five memory-clinic patients with subjective complaints were amyloid-positive

In 194 consecutive memory-clinic patients, amyloid PET positivity rose from 40.9% in those with subjective complaints to 91.7% in those with early Alzheimer's disease, with MRI adding nothing.

A retrospective analysis of 194 consecutive memory-clinic patients sent for amyloid PET compared positivity across subjective complaints, mild cognitive impairment and early Alzheimer's disease. Positivity rose stepwise, from 40.9% in those with subjective complaints to 66.0% in mild cognitive impairment. It reached 91.7% in early Alzheimer's disease, and MRI measures of brain shrinkage added nothing to the clinical diagnosis in predicting amyloid positivity.

Why it is interesting: Two in five with complaints but no measured impairment were amyloid-positive, so a biological definition would count them.

Source
Journal of Alzheimer’s Disease, 23 September 2026
Paper
Clinic-based real-world analysis of amyloid PET positivity and MRI markers across subjective cognitive decline, mild cognitive impairment, and early Alzheimer's disease
Authors
Arai H, Aiba S, Yamamoto H, Akiba Y, Takayama J, Arai R
DOI
10.1177/13872877261490596
Type
Peer-reviewed article
Design
Retrospective consecutive memory-clinic cohort, 194 patients undergoing 18F-florbetapir amyloid PET, MRI/VSRAD in 153
Verdict
Confirms prior evidence
Driver
Dementia

Other drivers in Health today